<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02784847</url>
  </required_header>
  <id_info>
    <org_study_id>UX007</org_study_id>
    <nct_id>NCT02784847</nct_id>
  </id_info>
  <brief_title>A Pilot Trial of Triheptanoin for the Preventive Treatment of Migraine</brief_title>
  <acronym>TRIMI</acronym>
  <official_title>A Pilot Trial of Triheptanoin for the Preventive Treatment of Migraine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Liege</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Liege</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A pilot trial of triheptanoin, a natural compound able to promote anaplerotic mitochondrial
      metabolism, for the preventative treatment of migraine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To test the ability of a daily 3-month treatment with triheptanoin to prevent migraine
      attacks in 10 migraine patients.

      This is an open, non-randomized pilot trial that might justify a placebo-controlled trial, if
      there are at least 50% of patients with ≥50% reduction in attack frequency.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">November 2016</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in monthly migraine days</measure>
    <time_frame>Between the 1-month baseline and the 3rd month of triheptanoin treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in mean attack severity</measure>
    <time_frame>Between the 1-month baseline and the 3rd month of triheptanoin treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in mean attack duration</measure>
    <time_frame>Between the 1-month baseline and the 3rd month of triheptanoin treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients who have at least a 50% reduction in monthly migraine days</measure>
    <time_frame>Between the 1-month baseline and the 3rd month of triheptanoin treatment</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Tolerance and gastrointestinal adverse effects</measure>
    <time_frame>During the 3 months of triheptanoin treatment</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Migraine</condition>
  <arm_group>
    <arm_group_label>treatment arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>pilot-study with single arm of 10 migraine patients treated for 3 months with triheptanoin 1mg/kg/day</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triheptanoin</intervention_name>
    <description>Triheptanoin oil administered three times per day during meals at a total dose 1mg/kg/day for 3 months</description>
    <arm_group_label>treatment arm</arm_group_label>
    <other_name>UX007</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Females aged 18-65 years old having an effective contraception or being menopaused

          -  Diagnosis of migraine without aura (ICHD3beta 1.1) since at least 2 years

          -  4-10 migraine days per month during the last 3 months

          -  No preventive anti-migraine therapy during the last month

        Exclusion Criteria:

          -  &gt; 4 tension-type headache episodes per month

          -  Medication overuse headache or other headache types

          -  Resistance to &gt;3 previous preventive anti-migraine drug treatments

          -  Any serious medical or psychiatric condition

          -  On-going or previous bowel disorder
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean Schoenen, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Liège</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean Schoenen, MD, PhD</last_name>
    <phone>+3242238663</phone>
    <email>jschoenen@ulg.ac.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Delphine Magis, MD, PhD</last_name>
    <phone>+3242256111</phone>
    <email>dmagis@chu.ulg.ac.be</email>
  </overall_contact_backup>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 10, 2016</study_first_submitted>
  <study_first_submitted_qc>May 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 27, 2016</study_first_posted>
  <last_update_submitted>May 24, 2016</last_update_submitted>
  <last_update_submitted_qc>May 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Liege</investigator_affiliation>
    <investigator_full_name>Jean Schoenen</investigator_full_name>
    <investigator_title>Honorary Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

